Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study (Q40231133)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 October 2013
edit
Language Label Description Also known as
English
Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study
scientific article published on 14 October 2013

    Statements

    Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study (English)
    0 references
    0 references
    0 references
    Amar-Singh Hss
    Mia-Tuang Koh
    Kah Kee Tan
    Lee Gaik Chan
    Lynn Zhou
    Alain Bouckenooghe
    Denis Crevat
    Yanee Hutagalung
    14 October 2013
    5814-5821

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit